SUNPHARMA vs TECHM: Stock Comparison

SUN PHARMACEUTICAL IND L vs TECH MAHINDRAUpdated 9 Oct 26, 4:08 PM ISTNSE & company filings

SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. SUN PHARMACEUTICAL IND L shows faster revenue growth and a higher net margin, while TECH MAHINDRA shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SUNPHARMA leads 5; TECHM leads 8 of 13

Not a rating
These companies operate in different sectors (Healthcare vs Information Technology). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SUNPHARMATECHM

Valuation lens

What price are you paying?

Market CapContext only
₹4.22 L Cr
₹1.49 L Cr
P/E RatioTECHM has the lower reading
34.85x
28.95x ✓
P/B RatioTECHM has the lower reading
5.04x
5.02x ✓
EPSTECHM has the higher reading
₹12.06
₹14.95 ✓
Book ValueContext only
₹349.6
₹306.89
Dividend YieldTECHM has the higher reading
0.91%
3.36% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SUNPHARMA is the larger company
₹4.22 L Cr vs ₹1.49 L Cr
P/E Ratio
TECHM has a lower P/E
28.95x vs 34.85x
P/B Ratio
TECHM has a lower P/B
5.02x vs 5.04x
EPS
TECHM has higher earnings per share
₹14.95 vs ₹12.06
Dividend Yield
TECHM has a higher dividend yield
3.36% vs 0.91%
Revenue Growth (TTM YoY)
SUNPHARMA has faster revenue growth
12.8% vs 12.6%
EPS Growth (TTM YoY)
SUNPHARMA has faster EPS growth
25.6% vs 15.9%
Qtr Sales Growth
SUNPHARMA has stronger quarterly sales growth
4.71% vs 4.22%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSUNPHARMATECHM
SectorHealthcareInformation Technology
IndustryPharmaceuticalsComputers - Software & Consulting

Price

MetricSUNPHARMATECHM
Live Price₹1,760₹1,514.1
Day Change0.01%1.2%
Volume13.46 L20.22 L
52-Week High₹2,046.9₹1,854
52-Week Low₹1,583.7₹1,304.1
Distance from 52W High-14.02%-18.33%

Valuation

MetricSUNPHARMATECHM
Market Cap₹4.22 L Cr₹1.49 L Cr
P/E Ratio34.85x28.95x
P/B Ratio5.04x5.02x
EPS₹12.06₹14.95
Book Value₹349.6₹306.89
Dividend Yield0.91%3.36%

Growth

MetricSUNPHARMATECHM
Revenue Growth (TTM YoY)12.8%12.6%
EPS Growth (TTM YoY)25.6%15.9%
Qtr Sales Growth4.71%4.22%
Qtr Profit Growth7.07%9.58%

Profitability & Leverage

MetricSUNPHARMATECHM
ROE11.76%17.77%
ROCE9.6%20.38%
Net Margin18.56%8.47%
Operating Margin22.81%11.09%
Debt to Equity0.6x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSUNPHARMATECHM
Promoter Holding54.48%34.94%▼ 0.01 pp
FII Holding14.53%▼ 1.4 pp18.66%▲ 0.07 pp
DII Holding22.18%▲ 1.07 pp36.92%▼ 0.41 pp
Public Holding8.81%▲ 0.33 pp9.29%▲ 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUN PHARMACEUTICAL IND L and TECH MAHINDRA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.